- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Measures to Assess Hospital Quality Are Flawed, Study Finds
The approach for assessing hospital penalties under the Hospital-Acquired Condition Reduction Program might need to be reconsidered in order to achieve the intended goal of the program.
approach for assessing hospital penalties under the
Hospital-Acquired Condition (HAC) Reduction Program might need to be reconsidered in order to achieve the intended goal of the program, according to findings published in JAMA.
relationship between the hospital quality summary score and HAC program penalization as well as publicly reported process-of-care and outcome measures from 4 clinical areas: surgery, acute myocardial infarction, heart failure, and pneumonia.
The findings of the study showed hospitals were more likely to be penalized if they had accreditations, offered advanced services, were major teaching institutions or performed better on other quality measures.
reduces payments to the lowest-performing hospitals, and researchers examined the
The HAC Reduction Program
The
“Higher-performing hospitals were penalized more because some of the measures that CMS uses to assess quality are flawed,” senior author Karl Bilimoria, MD, assistant professor in surgery-surgical oncology and director of the Surgical Outcomes and Quality Improvement Center, said in a statement. “The measures paradoxically identify high-performing hospitals as poor performers. Clearly this is not ideal for hospitals or for patients.”
ospitals with the highest quality score of 8 were penalized significantly more frequently than hospitals with the lowest quality score of 0.
Nearly one-fourth (22%) of participating hospitals were penalized and h
See the study: http://bit.ly/1PfhkJH
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: UnitedHealth Lawsuit; Fentanyl Crackdown; Global Heat Deaths Increase
November 15th 2023A class action lawsuit was filed against UnitedHealth Group and a subsidiary for allegedly using an algorithm to deny rehabilitation coverage for seriously ill patients; US and China officials are finalizing an agreement to crack down on fentanyl; a study published Tuesday projected global heat deaths to increase by 370% if no action is taken against global warming.
Read More
Overcoming Challenges to Value-Based Care Implementation: Grant Andres
November 10th 2023In an interview with The American Journal of Managed Care®, Grant Andres, BSc, DC, BSN, MSN-RN, senior director of clinical operations at Arizona Oncology, discussed the nuances of successfully implementing value-based care initiatives across a large organization.
Read More
